1997
DOI: 10.1038/sj.leu.2400745
|View full text |Cite
|
Sign up to set email alerts
|

Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk

Abstract: 18). In addition, TCR engagecharacteristic of 'memory' T lymphocytes. 1-5 A high percentment results in Zap70 activation after its binding to the tyrosylage of the malignant cells constitutively express BE2, a late phosphorylated immunoreceptor tyrosine-based activation activation marker of 78 kDa, that appears on cloned normal motifs (ITAMs) of the chains and the CD3 complex 23,24 (for T cells only after stimulation with specific antigen, and on review see Ref. 25) and in rapid tyrosine phosphorylation and f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
14
0

Year Published

1999
1999
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(19 citation statements)
references
References 12 publications
5
14
0
Order By: Relevance
“…20,29 It has already been noted that TCR signaling in CTCL tumor cells is reduced, along with decreased activity of Zap70, Syk, and membrane Csk. 41 Our results suggest that this deficiency may result at least in part from the overexpression of functional ILT2 inhibitory receptors. Finally, we found that circulating malignant Sézary cells may be separated from the nonmalignant reactive CD4 ϩ autologous T lymphocytes by means of anti-ILT2 mAb GHI/75.…”
Section: Discussionmentioning
confidence: 79%
“…20,29 It has already been noted that TCR signaling in CTCL tumor cells is reduced, along with decreased activity of Zap70, Syk, and membrane Csk. 41 Our results suggest that this deficiency may result at least in part from the overexpression of functional ILT2 inhibitory receptors. Finally, we found that circulating malignant Sézary cells may be separated from the nonmalignant reactive CD4 ϩ autologous T lymphocytes by means of anti-ILT2 mAb GHI/75.…”
Section: Discussionmentioning
confidence: 79%
“…44,45 A previous study has shown that the enzymatic activity of membrane-bound Csk is suppressed in tumor cells from patients with CTCL. 46 Furthermore, we found that the expression of Csk was down-regulated (albeit to a different extend) in the malignant CTCL cell lines relative to other T-cell lines ( Figure 4E). Collectively, these findings suggest that Blk is constitutively active in malignant CTCL cells and, further, that the aberrant activity is caused by autophosphorylation promoted by high abnormal expression of Blk combined with down-regulation of negative regulators of SFK activity such as Csk.…”
Section: Blk Is Constitutively Activementioning
confidence: 85%
“…The observations that the endogenous SFK inhibitor, Csk, is down-regulated in the malignant T-cell lines and that the activity of membrane-bound Csk is suppressed in tumor cells from patients with CTCL support this hypothesis. 46 It is possible, however, that other SFKs or non-SFK tyrosine kinases also play a role in the constitutive activation of Blk.…”
Section: Discussionmentioning
confidence: 99%
“…Similar to IL-10R and TGF-b receptor II, malignant T cells from advanced disease typically display decreased surface expression of CD3 and/or exhibit resistance to TCR stimulation and apoptosis. 51,64 By targeting the benign T cells, SEs may still influence the malignant T cells even as they become resistant to TCR stimulation. Moreover, the proposed indirect mechanism implies that the pathogenic role of SEs is not limited to cases of patients expressing a SE-responsive TCR Vb on the malignant clone.…”
Section: Discussionmentioning
confidence: 99%